EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy

Hongyu Li iD, Shuai Yang, Ke Zeng, Jiayin Guo, Jian Wu, Huaji Jiang, Yingchao Xie, Zhiqiang Hu, Jiansen Lu, Jianwu Yang, Xin-Zhuan Su iD, Jun Cui und 1 weitere

mBio · 2023

DOI: 10.1128/mbio.03512-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Hongyu Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Southern Medical University , Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Interferon Type I, Signal Transduction, Autophagy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province (), Guangdong Zhujiang Youth Scholar Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stringent control of the type I interferon (IFN-I) signaling is critical for host immune defense against infectious diseases, yet the molecular mechanisms that regulate this pathway remain elusive. Here, we show that Src homology 2 containing inositol phosphatase 1 (SHIP1) suppresses IFN-I signaling by promoting IRF3 degradation during malaria infection. Genetic ablation of Ship1 in mice leads to high levels of IFN-I and confers resistance to Plasmodium yoelii nigeriensis ( P.y. ) N67 infection. Mechanistically, SHIP1 promotes the selective autophagic degradation of IRF3 by enhancing K63-linked ubiquitination of IRF3 at lysine 313, which serves as a recognition signal for NDP52-mediated selective autophagic degradation. In addition, SHIP1 is downregulated by IFN-I-induced miR-155-5p upon P.y . N67 infection and severs as a feedback loop of the signaling crosstalk. This study reveals a regulatory mechanism between IFN-I signaling and autophagy, and verifies SHIP1 can be a potential target for therapeutic intervention against malaria and other infectious diseases. IMPORTANCE Malaria remains a serious disease affecting millions of people worldwide. Malaria parasite infection triggers tightly controlled type I interferon (IFN-I) signaling that plays a critical role in host innate immunity; however, the molecular mechanisms underlying the immune responses are still elusive. Here, we discover a host gene [Src homology 2-containing inositol phosphatase 1 (SHIP1)] that can regulate IFN-I signaling by modulating NDP52-mediated selective autophagic degradation of IRF3 and significantly affect parasitemia and resistance of Plasmodium -infected mice. This study identifies SHIP1 as a potential target for immunotherapies in malaria and highlights the crosstalk between IFN-I signaling and autophagy in preventing related infectious diseases. SHIP1 functions as a negative regulator during malaria infection by targeting IRF3 for autophagic degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesInterferon Type ISignal TransductionAutophagyMalariaPlasmodium yoeliiAnimalsMiceInterferon Regulatory Factor-3Mice, KnockoutMice, Inbred C57BLHumans

Stichwörter der Autor:innen

IRF3PlasmodiumSHIP1autophagytype I interferon

Substanzen

Phosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesInterferon Type IInterferon Regulatory Factor-3Inpp5d protein, mouseIrf3 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Southern Medical University , Guangzhou, Guangdong, China.
  • Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University , Guangzhou, Guangdong, China.
  • Malaria Functional Genomics Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland, USA.
  • Yue Bei People's Hospital Postdoctoral Innovation Practice Base, Southern Medical University , Guangzhou, Guangdong, China.
  • Department of Joint Surgery, the Fifth Affiliated Hospital of Southern Medical University , Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Lab of Single Cell Technology and Application, Southern Medical University , Guangzhou, Guangdong, China.

ORCID-Profile: Hongyu Li, Xin-Zhuan Su, Xiao Yu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()
  • Guangdong Zhujiang Youth Scholar Funding
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
  • The Star-up Fund for High-level talents of Southern Medical University

Zitieren

APA

Li, H., Yang, S., Zeng, K., Guo, J., Wu, J., Jiang, H., Xie, Y., Hu, Z., Lu, J., Yang, J., Su, X. Z., Cui, J., & Yu, X. (2023). SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy. mBio. https://doi.org/10.1128/mbio.03512-22

Vancouver

Li H, Yang S, Zeng K, Guo J, Wu J, Jiang H, et al. SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy. mBio. 2023. doi:10.1128/mbio.03512-22

BibTeX
@article{Li2023,
  author = {Li, Hongyu and Yang, Shuai and Zeng, Ke and Guo, Jiayin and Wu, Jian and Jiang, Huaji and Xie, Yingchao and Hu, Zhiqiang and Lu, Jiansen and Yang, Jianwu and Su, Xin-Zhuan and Cui, Jun and Yu, Xiao},
  title = {SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.03512-22}
}
Kostenlos starten →